Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
TB-500 Research Peptide is linked to thymosin beta-4 fragment research and is commonly studied through actin binding, cell migration, tissue remodelling, angiogenesis and repair-associated marker panels
This category can include BPC-157, TB-500, BPC-157 + TB-500 blends, and related support products
Autoimmune prostatitis in Balb/C mice was induced by a homogenate of the reproductive tissues of male rats
The complexity requires careful monitoring and solid experience with peptide handling, reconstitution, and injection technique
Daily dose: 2,330mcg (2.33mg) total blend This breaks down to approximately: 1,700mcg (1.7mg) GHK-Cu 330mcg TB-500 330mcg BPC-157 Administration: Once daily, subcutaneous injection Cycle length: 4 weeks, followed by 2-4 week rest period Schedule: Daily injection at consistent time For a standard 70mg glow peptide vial reconstituted with 3mL bacteriostatic water, this protocol requires 0.10mL (10 units on an insulin syringe) per daily injection
